Gastroenterology

Gastroenterology

Volume 154, Issue 3, February 2018, Pages 752-754.e1
Gastroenterology

Correspondence
Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

https://doi.org/10.1053/j.gastro.2017.08.067Get rights and content

Section snippets

Acknowledgments

The authors gratefully acknowledge the healthy controls and the patients with IBD involved in this study.

References (8)

  • U. Mahadevan

    Gastroenterology

    (2016)
  • M. Julsgaard

    Gastroenterology

    (2016)
  • D.C. Baumgart

    Aliment Pharmacol Ther

    (2016)
  • M. Julsgaard

    Gut

    (2017)
There are more references available in the full text version of this article.

Cited by (0)

This study was supported by unrestricted grants by the Colitis-Crohn Denmark and the A.P. Moeller Foundation of the Advancement of Medical Science.

Conflicts of interest The authors have made the following disclosures: MJ, JK, and DCB have received speaker’s fees from and/or served as scientific advisers to Takeda, the manufacturer of vedolizumab. The remaining authors disclose no conflicts. Takeda had no role in the design, collection of data, or interpretation of the results of this study.

Authors names in bold designate shared co-first authors.

View full text